• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Biden-Harris administration using taxpayer money to mask Medicare premium hikes before election: critics

by August 14, 2024
written by August 14, 2024

In a move critics say is designed to shield the Biden-Harris administration from election fallout, the administration has leveraged taxpayer funds to mask upcoming increases in Medicare premiums.

Under the Inflation Reduction Act (IRA), which was intended to cap out-of-pocket drug costs for Medicare beneficiaries, insurers are poised to significantly hike monthly premiums, with average bids for Part D plans expected to triple by 2025.

In response to potential voter backlash, the Centers for Medicare and Medicaid Services (CMS) rolled out a three-year ‘demonstration project’ to subsidize these premiums, aiming to keep them artificially low. However, despite the appearance of relief, some critics are saying that taxpayers will fund a dramatic increase in subsidies — from $30 per recipient per month in 2024 to $142.70 in 2025 — raising concerns about the long-term impact on government spending and debt. 

Former President Trump advisor Joe Grogan has criticized the maneuver, arguing that it merely shifts costs rather than providing real relief.

‘They’ve destroyed part D premiums,’ Grogan told Fox News Digital in an interview. ‘I’m not sure it’ll survive legal scrutiny if someone were to sue. Objectively, it shouldn’t be done. It’s just interjecting $5-10 billion of taxpayer dollars, while the taxpayers are paying the price 85 days before an election. It’s sickening.’

‘This is only going to get worse in 2025, 2026,’ Grogan continued. ‘The program is in a death spiral. They announced a three-year demo. It’s already broken. The demo is going to fail. Premiums are still going to go up.’

Paragon Health Institute, a health care research group, called the CMS demo plan a ‘fake, costly demonstration,’ in a recent analysis. 

‘Fearing the premium increases that the IRA redesign will impose on Part D plans, CMS has now launched a new voluntary, nationwide demonstration program that is neither a demonstration nor voluntary. Unlike this massive subsidization scheme, demonstrations are supposed to be limited in nature and test alternative features of program design,’ the institute wrote. ‘As a result of the IRA changes, insurers that don’t participate are expected to either be uncompetitive from a price perspective or face significant losses – hardly a choice for insurers.’

Research published by Fidelity, an investment research group, shows that a 65-year-old retiring today can expect to spend $165,000 on health care in retirement, a 5% increase from last year and more than double the estimate from 2002.

Yet, there appears to be a disconnect for many Americans between the actual projected cost of health care in retirement and how much they expect to spend on those expenses. The average American thinks they will spend about $75,000 on health care and other medical expenses, less than half of Fidelity’s calculation, according to the research.

The estimate assumes that an individual is enrolled in Medicare – including Part A and Part B, which cover most hospital care and doctor’s visits – and Part D, which covers prescription drugs. Other expenses such as Medicare premiums, over-the-counter medications, dental and vision care and other costs typically not covered by Medicare are ‘left to retirees to manage on their own,’ the report said.

As of April 2024, about 67.3 million Americans were enrolled in Medicare, according to the Centers for Medicare and Medicaid Services. Of those, about half were enrolled in a Medicare Advantage plan, while about 80% were covered by Medicare Part D.

‘They just want to get through the election,’ Grogan said. ‘They’re hoping after the election they can face it, but its gonna need to be dealt with in the next 12–18 months. They did not believe it would be this bad and its only gonna get worse.’ 

Americans are also dealing with a spike in the cost of prescription drugs, which has surged nearly 40% over the past decade, easily outstripping the pace of inflation. 

Fox News Digital has reached out to CMS for comment. 

Fox Business’ Megan Henney contributed to this report. 

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Oil and natural gas: oil price in retreat since Tuesday
next post
The dollar index under strong bearish pressure this week

related articles

Trump declares himself Venezuela’s ‘acting president’ in online...

January 12, 2026

Iran’s Khamenei issues direct warning to United States...

January 12, 2026

Trump’s Greenland push escalates as GOP lawmaker moves...

January 12, 2026

US hostages in Iran face heightened risk as...

January 12, 2026

GOP eyes Venezuela’s untapped oil wealth as Democrats...

January 12, 2026

Republican senator vows to block Trump Fed nominee...

January 12, 2026

DHS funding threatened as Congress rolls out $80B...

January 12, 2026

Inside the lightning US strike that overwhelmed Venezuela’s...

January 12, 2026

As Trump urges deal, Cuban president warns that...

January 12, 2026

I was told I was a boy. Supreme...

January 12, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Delta Airlines cancellations and delays continue but worst of IT outage impact is over, CEO says

    July 25, 2024
  • ‘Stealing American jobs’: Anti-CCP group unleashes ad demanding GOP lawmakers back Trump on saving US farms

    January 23, 2025
  • Is the woke era over?

    November 22, 2024
  • President Biden set to deliver farewell speech to the nation

    January 15, 2025
  • Starbucks announces several changes, including plans to cut some menu items

    January 30, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024

Categories

  • Economy (829)
  • Editor's Pick (7,418)
  • Investing (814)
  • Stock (965)

Latest Posts

  • Arab Americans sour on Democrats amid war in Middle East: Activist says Trump outreach has been ‘surreal’

    October 20, 2024
  • Trump health secretary nominee RFK Jr survives heated hearings ahead of crucial confirmation votes

    January 31, 2025
  • Biden’s team hid the truth about his health all along: WH press sec

    April 11, 2025

Recent Posts

  • House GOP plan to avert government shutdown on life support as Johnson delays vote

    September 11, 2024
  • DOJ forms Russiagate ‘strike force’ to investigate declassified Obama-era evidence

    July 24, 2025
  • Top Republicans accuse FTC chair of Hatch Act violations over ‘campaign-style events’ with Dems

    October 22, 2024

Editor’s Pick

  • Commodity wrap: silver smashes past $70/oz on firm demand, gold hits record high

    December 24, 2025
  • US Treasury targets Houthi-linked vessels to disrupt efforts to fund ‘dangerous and destabilizing attacks’

    April 28, 2025
  • Rhode Island’s ‘Taylor Swift Tax’ on vacation homes of the wealthy is spreading to other states

    September 2, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock